Guardant Health, Inc. 4

Co-CEO Helmy Eltoukhy reclassified 35,000 shares of Guardant Health common stock from his revocable trust to The Eltoukhy Foundation with no change in total beneficial ownership.

On August 11, 2026, Guardant Health, Inc. Co-Chief Executive Officer Helmy Eltoukhy reported an internal reclassification of 35,000 shares of Guardant Health common stock, transferring them at no cost from the Helmy A. Eltoukhy Revocable Trust to The Eltoukhy Foundation. The Form 4 indicates this was a change in the form of beneficial ownership rather than an open-market transaction, with no price per share or transaction value reported and no change in Mr. Eltoukhy’s aggregate beneficial ownership of Guardant Health shares. Following the transaction, the Form 4 reports that 1,995,934 shares remain held indirectly via the revocable trust, while 35,000 shares are now held indirectly via The Eltoukhy Foundation.

Filing Facts

CIK

1576280

Ticker

GH

Form

4

Source Type

sec

Accession

0001752968-26-000014

Alert Tier

4